194 related articles for article (PubMed ID: 34916042)
21. Efficacy and safety of abobotulinumtoxinA liquid formulation in cervical dystonia: A randomized-controlled trial.
Poewe W; Burbaud P; Castelnovo G; Jost WH; Ceballos-Baumann AO; Banach M; Potulska-Chromik A; Ferreira JJ; Bihari K; Ehler E; Bares M; Dzyak LA; Belova AN; Pham E; Liu WJ; Picaut P
Mov Disord; 2016 Nov; 31(11):1649-1657. PubMed ID: 27653448
[TBL] [Abstract][Full Text] [Related]
22. Botulinum Toxin Type A Injection for Cervical Dystonia in Adults with Dyskinetic Cerebral Palsy.
Yi YG; Kim K; Yi Y; Choi YA; Leigh JH; Bang MS
Toxins (Basel); 2018 May; 10(5):. PubMed ID: 29772695
[TBL] [Abstract][Full Text] [Related]
23. A mixed treatment comparison to compare the efficacy and safety of botulinum toxin treatments for cervical dystonia.
Han Y; Stevens AL; Dashtipour K; Hauser RA; Mari Z
J Neurol; 2016 Apr; 263(4):772-80. PubMed ID: 26914922
[TBL] [Abstract][Full Text] [Related]
24. Decreased neck muscle strength is highly associated with pain in cervical dystonia patients treated with botulinum toxin injections.
Häkkinen A; Ylinen J; Rinta-Keturi M; Talvitie U; Kautiainen H; Rissanen A
Arch Phys Med Rehabil; 2004 Oct; 85(10):1684-8. PubMed ID: 15468031
[TBL] [Abstract][Full Text] [Related]
25. Efficacy of single-photon emission computed tomography aided botulinum toxin injection in cervical dystonia: A double-blind, randomized study.
Teng F; Malam Djibo I; Chen S; Su J; Pan Y; Zhang X; Xu Y; Feng L; Pan L; Jin L
Parkinsonism Relat Disord; 2021 Oct; 91():77-82. PubMed ID: 34537494
[TBL] [Abstract][Full Text] [Related]
26. Botulinum Toxin Injections to the Obliquus Capitis Inferioris Muscle for Dynamic Cervical Dystonia Improves Subjective Patient Outcomes.
Bessemer RA; Jog M
Toxins (Basel); 2024 Feb; 16(2):. PubMed ID: 38393155
[TBL] [Abstract][Full Text] [Related]
27. Overview of DaxibotulinumtoxinA for Injection: A Novel Formulation of Botulinum Toxin Type A.
Solish N; Carruthers J; Kaufman J; Rubio RG; Gross TM; Gallagher CJ
Drugs; 2021 Dec; 81(18):2091-2101. PubMed ID: 34787840
[TBL] [Abstract][Full Text] [Related]
28. Efficacy analysis of ultrasound-guided local injection of botulinum toxin type A treatment with orthopedic joint brace in patients with cervical dystonia.
Huang L; Chen HX; Ding XD; Xiao HQ; Wang W; Wang H
Eur Rev Med Pharmacol Sci; 2015; 19(11):1989-93. PubMed ID: 26125259
[TBL] [Abstract][Full Text] [Related]
29. A prospective, randomized, double-blind study comparing the efficacy and safety of type a botulinum toxins botox and prosigne in the treatment of cervical dystonia.
Quagliato EM; Carelli EF; Viana MA
Clin Neuropharmacol; 2010; 33(1):22-6. PubMed ID: 19959960
[TBL] [Abstract][Full Text] [Related]
30. Botulinum toxin type B vs. type A in toxin-naïve patients with cervical dystonia: Randomized, double-blind, noninferiority trial.
Pappert EJ; Germanson T;
Mov Disord; 2008 Mar; 23(4):510-7. PubMed ID: 18098274
[TBL] [Abstract][Full Text] [Related]
31. The clinical utility of botulinum toxin injections targeted at the motor endplate zone in cervical dystonia.
Delnooz CC; Veugen LC; Pasman JW; Lapatki BG; van Dijk JP; van de Warrenburg BP
Eur J Neurol; 2014 Dec; 21(12):1486-e98. PubMed ID: 25060697
[TBL] [Abstract][Full Text] [Related]
32. Sensorimotor Perceptive Rehabilitation Integrated (SPRInt) program: exercises with augmented movement feedback associated to botulinum neurotoxin in idiopathic cervical dystonia-an observational study.
Castagna A; Caronni A; Crippa A; Sciumè L; Giacobbi G; Corrini C; Montesano A; Ramella M
Neurol Sci; 2020 Jan; 41(1):131-138. PubMed ID: 31478151
[TBL] [Abstract][Full Text] [Related]
33. Clinical profile of botulinum toxin A in patients with chronic headaches and cervical dystonia: a prospective, open-label, longitudinal study conducted in a naturalistic clinical practice setting.
Dowson AJ; Kilminster SG; Salt R
Drugs R D; 2008; 9(3):147-58. PubMed ID: 18457467
[TBL] [Abstract][Full Text] [Related]
34. Clinical features of cervical dystonia patients classified by the COL-CAP concept and treated with ultrasound-guided botulinum neurotoxin.
Szabó M; DO Kiem D; Gárdián G; Szpisjak L; Salamon A; Klivényi P; Zádori D
Ideggyogy Sz; 2023 Jan; 76(1-2):37-45. PubMed ID: 36892297
[TBL] [Abstract][Full Text] [Related]
35. Botulinum toxin and conservative treatment strategies in people with cervical dystonia: an online survey.
Boyce MJ; McCambridge AB; Bradnam LV; Canning CG; De Oliveira CQ; Verhagen AP
J Neural Transm (Vienna); 2024 Jan; 131(1):43-51. PubMed ID: 37831150
[TBL] [Abstract][Full Text] [Related]
36. British Neurotoxin Network recommendations for managing cervical dystonia in patients with a poor response to botulinum toxin.
Marion MH; Humberstone M; Grunewald R; Wimalaratna S
Pract Neurol; 2016 Aug; 16(4):288-95. PubMed ID: 26976927
[TBL] [Abstract][Full Text] [Related]
37. Sonographic Guide for Botulinum Toxin Injections of the Neck Muscles in Cervical Dystonia.
Kaymak B; Kara M; Gürçay E; Özçakar L
Phys Med Rehabil Clin N Am; 2018 Feb; 29(1):105-123. PubMed ID: 29173657
[TBL] [Abstract][Full Text] [Related]
38. Ultrasound and Electromyography Guidance for Injection of the Longus Colli With Botulinum Toxin for the Treatment of Cervical Dystonia.
Allison SK; Odderson IR
Ultrasound Q; 2016 Sep; 32(3):302-6. PubMed ID: 26886108
[TBL] [Abstract][Full Text] [Related]
39. Improving the Efficacy of Botulinum Toxin for Cervical Dystonia: A Scoping Review.
Erro R; Picillo M; Pellecchia MT; Barone P
Toxins (Basel); 2023 Jun; 15(6):. PubMed ID: 37368692
[TBL] [Abstract][Full Text] [Related]
40. Cumulative effects of long-term treatment with abobotulinumtoxinA in cervical dystonia: Findings from a prospective, observational study.
Colosimo C; Charles D; Misra VP; Maisonobe P; Om S;
J Neurol Sci; 2020 Sep; 416():117015. PubMed ID: 32682125
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
